Eastern Europe and Balkan Region Refresher Course on Gynaecological Tumours
9 ESCO credits
11.10.2018 - 12.10.2018
Sarajevo, Bosnia-Herzegovina
REFRESHER COURSE
Description
Chairs: S. Beslija, BA - C. Sessa, CH
The Refresher Course on Gynaecological Tumours has been designed for medical and clinical oncologists of the Eastern Europe and Balkan Region, with the aim to provide an update on the -state of-the art therapeutic options as well as an overview of the latest advances in the field.
The programme will offer educational lectures covering updates on the diagnosis and treatment of both early and advanced gynaecological cancers. Moreover, spotlight lectures will discuss specific issues related to particular situations such as gynaecological cancer in young women or survivorship issues.
Practical training will be offered in the frame of clinical case presentations, prepared and presented by participants and discussed with the faculty with interactive voting.
LEARNING OBJECTIVES
• Update on the latest advances in diagnostic procedure
• Update on the latest advances and on the state-of- the-art treatment options
• Learn about the management of specific situations
• Debate controversies and challenges in gynaecological cancer treatment
• Improve practical skills in multidisciplinary management and follow-up of gynaecological cancer patients
MAIN TOPICS
• Update on standard and new diagnostic, treatment options and approaches
• Signalling pathways
• Gynaecological cancer pathology
• Systemic treatment of early and advanced gynaecological cancer
Faculty
FACULTY
S. Beslija, Institute of Oncology, University Clinical Center, Sarajevo, BA
A. Eniu, Cancer Institute "Ion Chiricuta”, Cluj-Napoca, RO
C. Fotopoulou, Imperial College London, Faculty of Medicine, Surgery & Cancer Dpt., London, UK
B. Hasanbegovic, Institute of Oncology, University Clinical Center, Sarajevo, BA
V. Kesic, Clinical Center of Serbia, Obstetrics and Gynaecology Dpt., Belgrade, SR
D. Lorusso, Fondazione IRCCS Istituto Nazionale dei Tumori, SC Chirurgia Ginecologica, Milano, IT
A. Pasic, Institute of Oncology, University Clinical Center, Sarajevo, BA
C. Sessa, Oncology Institute of Southern Switzerland, Medical Oncology Dept., Bellinzona, CH
Z. Tomaševic , Institute for Oncology and Radiology of Serbia, Daily Chemotherapy Hospital, Belgrade, SR
General information
ORGANISING SECRETARIAT
Laura Richetti
European School of Oncology (ESO)
Piazza Indipendenza 2
6500 Bellinzona
ph +41 91 820 09 51
e-mail: lrichetti@eso.net
OFFICIAL LANGUAGE
The official language will be English. No translation will be available.
IMPORTANT DEADLINES |
||
Application by: | 15 June 2018 | |
---|---|---|
Save event date: | 11 October 2018 |
Application
PARTICIPANT’S PROFILE
• Age between 30 and 45 years
• 2-4 years’ experience in oncology
• Involvement in scientific activities and clinical trials
• Fluency in English
• Practicing in Eastern Europe and Balkan Region
Priority will be given to medical and clinical oncologists who have attended a previous edition of the Eastern Europe and Balkan Region Masterclass in Medical/Clinical Oncology
PARTICIPATION
Attendance is limited and admittance is by competitive application only.
Successful applicants are granted free registration, welcome dinner, lunches and coffee breaks.
Free accommodation at the course venue for arrival on 10 October and departure on 12 October will be provided to participants not residing in the Sarajevo area.
ACCREDITATION
The event has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS). The evaluation of the event has been performed by the Accreditation Council of Oncology in Europe (ACOE) that acknowledged the quality of the scientific programme and its educational value. The event is designated for a maximum of 10 European CME credits (ECMEC). Through an agreement between UEMS and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.
Participants will receive their certificate of attendance via e-mail after the event on completion of the evaluation form.
ATTENDANCE TO THE COURSE IS BY APPLICATION ONLY
THE APPLICATION DEADLINE HAS PASSED (24 JUNE 2018)
Programme
10 October |
|
18:00 | Registration |
19:30 | Welcome dinner |
11 October |
|
7:45 | Registration |
8:00 | Welcome address, general introduction and ESO EEBR Programme A. Eniu, RO - S. Beslija, BA - C. Sessa, CH |
FIRST SESSION: OVARIAN CANCER | |
8:30 | Current standard of care in ovarian cancer C. Sessa, CH |
8:50 | Discussion |
9:00 | Optimal treatment of platinum sensitive BRCA mutated ovarian cancer B. Hasanbegovic, BA |
9:20 | Discussion |
9:30 | PARP testing and indications for PARP inhibitors D. Lorusso, IT |
9:50 | Discussion |
10:00 | Immunotherapy in ovarian cancer D. Lorusso, IT |
10:20 | Discussion |
10:30 | Coffee break |
11:00 | Tumor board: Selected clinical cases presented by participants and discussed with the faculty Four clinical cases presented by participants |
12:15 | Lunch |
SECOND SESSION: ENDOMETRIAL CANCER | |
13:30 | ESMO-ESGO-ESTRO Guidelines for Endometrial Cancer C. Sessa, CH |
13:50 | Discussion |
14:00 | Risk factors and pathogenesis of endometrial cancer in young women V. Kesic, SR |
14:20 | Discussion |
14:30 | Conservative management of atypical hyperplasia and early endometrial cancer V. Kesic, SR |
14:50 | Discussion |
15:00 | Adjuvant treatment of endometrial cancer based on risk groups Z. Tomaševic, SR |
15:20 | Discussion |
15:30 | Coffee break |
16:00 | Treatment of metastatic endometrial cancer D. Lorusso, IT |
16:20 | Discussion |
16:30 | Tumor board: Selected clinical cases presented by participants and discussed with the faculty Four clinical cases presented by participants |
12 October |
|
THIRD SESSION: CERVICAL CANCER | |
8:15 | ESGO-ESTRO-ESP Guidelines for management of cervical cancer C. Sessa, CH |
8:35 | Discussion |
8:45 | Management of stages Ib1/Ia1 cervical cancer C. Fotopoulou, UK |
9:05 | Discussion |
9:15 | Fertility preservation in early cervical cancer A. Pasic, BA |
9:35 | Discussion |
9:45 | Management of locally advanced cervical cancer C. Fotopoulou, UK |
10:15 | Discussion |
10:30 | Coffee break |
10:50 | Treatment of metastatic cervical carcinoma A. Pasic, BA |
11:10 | Discussion |
11:20 | Tumor board: Selected clinical cases presented by participants and discussed with the faculty |
12:20 | Closing remarks S. Beslija, BA - C. Sessa, CH |
12:35 | Light lunch |